|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 193.54 USD | -7.41% |
|
-2.37% | +14.11% |
| 06:45pm | Biogen's Alzheimer's drug lowers toxic protein, but results were mixed | RE |
| 10:08am | Leqembi can now be administered at home from the start of treatment in the US | FW |
| Market Cap | 3.09TCr 2.71TCr 2.51TCr 2.31TCr 4.36TCr 2,95400Cr 4.45TCr 30TCr 12TCr 1,45100Cr 12TCr 11TCr 5,00900Cr | P/E 2026 * |
34.8x | P/E 2027 * | 17.5x |
|---|---|---|---|---|---|
| Enterprise Value | 3.64TCr 3.19TCr 2.95TCr 2.72TCr 5.14TCr 3,48100Cr 5.24TCr 35TCr 14TCr 1,70900Cr 14TCr 13TCr 5,90400Cr | EV / Sales 2026 * |
3.61x | EV / Sales 2027 * | 3.29x |
| Free-Float |
85.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Biogen Inc.
| 1 day | -7.41% | ||
| 1 week | -2.37% | ||
| Current month | -7.05% | ||
| 1 month | +1.10% | ||
| 3 months | +12.22% | ||
| 6 months | +18.61% | ||
| Current year | +14.11% |
| 1 week | 194.37 |  | 210.87 |
| 1 month | 193.2 | | 219.72 |
| Current year | 160.36 | | 219.72 |
| 1 year | 121.05 | | 219.72 |
| 3 years | 110.04 | | 281.12 |
| 5 years | 110.04 | | 351.86 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Guy Hadari
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
William Hawkins
BRD | Director/Board Member | 72 | 19/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Chairman | 2,005 | 0.0014% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.41% | -2.37% | +50.87% | -28.00% | 3.09TCr | |
| -0.88% | -3.05% | +14.90% | -8.75% | 6.75TCr | |
| -1.36% | -8.63% | +34.40% | +192.36% | 5.11TCr | |
| +0.36% | +40.00% | +40.00% | +40.00% | 4.34TCr | |
| +1.34% | -0.81% | -49.11% | -52.89% | 4.03TCr | |
| -0.01% | -15.97% | +103.92% | -44.76% | 2.66TCr | |
| -0.50% | -3.78% | +62.31% | +83.92% | 2.28TCr | |
| +1.07% | +3.27% | +9.82% | +177.50% | 1.98TCr | |
| -1.32% | -5.21% | +53.96% | +123.60% | 1.65TCr | |
| -0.42% | +5.42% | +72.22% | +350.77% | 1.63TCr | |
| Average | -0.87% | -2.58% | +39.33% | +83.37% | 3.35TCr | |
| Weighted average by Cap. | -0.89% | -2.57% | +31.43% | +59.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.01TCr 882.72Cr 817.57Cr 752.25Cr 1.42TCr 96TCr 1.45TCr 9.74TCr 3.82TCr 47TCr 3.78TCr 3.7TCr 1,63400Cr | 1.04TCr 911.99Cr 844.68Cr 777.19Cr 1.47TCr 1LCr 1.5TCr 10TCr 3.95TCr 49TCr 3.9TCr 3.82TCr 1,68800Cr |
| Net income | 139.36Cr 122.23Cr 113.21Cr 104.17Cr 197.03Cr 13TCr 200.86Cr 1.35TCr 529.2Cr 6.55TCr 523.31Cr 511.87Cr 23TCr | 196.79Cr 172.61Cr 159.87Cr 147.09Cr 278.22Cr 19TCr 283.64Cr 1.91TCr 747.3Cr 9.25TCr 738.98Cr 722.82Cr 32TCr |
| Net Debt | 550.87Cr 483.17Cr 447.51Cr 411.76Cr 778.82Cr 53TCr 793.97Cr 5.33TCr 2.09TCr 26TCr 2.07TCr 2.02TCr 89TCr | 338.49Cr 296.89Cr 274.98Cr 253.01Cr 478.55Cr 32TCr 487.86Cr 3.28TCr 1.29TCr 16TCr 1.27TCr 1.24TCr 55TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | $199.22 | -4.69% | 1,11,801 |
| 13/26/13 | $209.03 | +4.96% | 22,59,821 |
| 10/26/10 | $199.15 | +0.12% | 11,33,120 |
| 09/26/09 | $198.91 | -0.72% | 16,57,327 |
| 08/26/08 | $200.36 | -2.60% | 19,47,888 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
